Φορτώνει......
Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management
BACKGROUND: Drug-induced colitis is a known complication of therapies that alter the immune balance, damage the intestinal barrier or disturb intestinal microbiota. Immune checkpoint inhibitors (ICI) directed against cancer cells may result in activated T lymphocyte-induced immune-related adverse ev...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Therap Adv Gastroenterol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
SAGE Publications
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6831976/ https://ncbi.nlm.nih.gov/pubmed/31723355 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756284819884196 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|